MedTrace Logo

The Cognitive Enhancing Effects of D-Cycloserine Among Non-Demented Elderly

NCT01361633 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2021-02-18

Study results available
· View outcomes & findings →

Summary

The goal of this study is to determine whether a study medication (d-cycloserine) improves the ability of older adults to perform on tests of neuropsychological functioning. Tests of neuropsychological functioning assess attention, memory, and executive functioning skills (for example, problem-solving, planning and organizing skills). It was hypothesized that participants who received study medication would perform better on neuropsychological tests than would participants who received the sugar pill.

Conditions

  • Treatment
  • Placebo

Interventions

DRUG

d-cycloserine

single oral administration of 250 mg d-cycloserine

DRUG

Sugar Pill

Single oral administration 250 mg Sugar Pill

Sponsors & Collaborators

  • Hartford Hospital

    lead OTHER

Principal Investigators

  • Gretchen J. Diefenbach, Ph.D. · Hartford Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01361633 on ClinicalTrials.gov